Skip to content

   
Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.
Latest news
> 8 May 2008 : AstraZeneca Submits sNDA for Seroquel XR™ for the Treatment of Generalised Anxiety Disorder – a First for the Atypical Antipsychotic Class of Medicines
> 6 May 2008 : EPO Announces Symbicort® European COPD Use Patent Decision
> 2 May 2008 : AstraZeneca Files Marketing Application in Europe for EGFR Inhibitor Gefitinib (IRESSA™) in Locally Advanced Pre-Treated Non-Small Cell Lung Cancer
Features
Read more about our new Code of Conduct, which reflects our continued commitment to doing business the right way.
AstraZeneca websites
Search
Quick links
Information for
US visitors
Share price
> London
> New York
> Stockholm
AstraZeneca news feed
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008